{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:34:42Z","timestamp":1773275682484,"version":"3.50.1"},"reference-count":72,"publisher":"Japan Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2006]]},"DOI":"10.1507\/endocrj.kr-77","type":"journal-article","created":{"date-parts":[[2006,8,30]],"date-time":"2006-08-30T05:40:03Z","timestamp":1156916403000},"page":"441-448","source":"Crossref","is-referenced-by-count":26,"title":["Follicular Thyroid Carcinoma: From Diagnosis to Treatment"],"prefix":"10.1507","volume":"53","author":[{"given":"Jen-Der","family":"LIN","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Department of General Surgery, Chang Gung Memorial Hospital, Chang Gung University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Chieh","family":"CHAO","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Department of General Surgery, Chang Gung Memorial Hospital, Chang Gung University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.43.997"},{"key":"2","unstructured":"2. Lin JD, Chao TC, See LC, Weng HF, Ho YS (1998) Poor prognosis of 56 follicular thyroid carcinomas with distant metastases at the time of diagnosis. Cancer J 11: 190-195."},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-8467(00)00088-3"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1827.2000.01065.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Reynolds RM, Weir J, Stockton DL, Brewster DW, Sandeep TC, Strachan MW (2005) Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol 62: 156-162.","DOI":"10.1111\/j.1365-2265.2004.02187.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Lin JD, Chao TC, Sun JH, Ho C, Weng HF (2000) Trends in the clinical characteristics of patients with papillary thyroid carcinoma in Taiwan. Oncology 58: 280-285.","DOI":"10.1159\/000012113"},{"key":"7","unstructured":"7. Rajesh L, Saha M, Radhika S, Das Radotra B, Rajwanshi A (2004) Morphometric image analysis of follicular lesions of the thyroid. Anal Quant Cytol Histol 26: 117-120."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Farahati J, Geling M, Mader U, Mortl M, Luster M (2004) Changing trends of incidence and prognosis of thyroid carcinoma in lower Franconia, Germany, from 1981-1995. Thyroid 14: 141-147.","DOI":"10.1089\/105072504322880382"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Lin JD, Kao PF, Weng HF, Lu WT, Huang MJ (1998) Relative value of thallium-201, and iodine-131 scans in the detection of the recurrence or distant metastasis of well differentiated thyroid carcinoma. Eur J Nucl Med 25: 695-700.","DOI":"10.1007\/s002590050271"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kumnig G (2002) Value of F-18 fluorodeoxyglucose positron emission tomography in thyroid carcinoma. Wien Med Wochenschr 152: 280-285.","DOI":"10.1046\/j.1563-258X.2002.02022.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Erdem S, Bashekim C, Kizilkaya E, Ince M, Karsli F (1997) Clinical application of Tc-99m tetrofosmin scintigraphy in patients with cold thyroid nodules. Comparison with color Doppler sonography. Clin Nucl Med 22: 76-79.","DOI":"10.1097\/00003072-199702000-00002"},{"key":"12","unstructured":"12. Krenik E, Gallowitsch HJ, Mikosch P, Molnar M, Pipan W, Gomez I, Lind P (1997) Evaluation of thyroid nodules with technetium-99m tetrofosmin dual-phase scintigraphy. Eur J Nucl Med 24: 716-721."},{"key":"13","unstructured":"13. Bloom AD, Adler LP, Shuck JM (1993) Determination of malignancy of thyroid nodules with positron emission tomography. Surgery 114: 728-734."},{"key":"14","unstructured":"14. Shechtman L, Koren R, Horowitz A, Shechtman I, Halpern M, Gal R (1998) Diagnostic value of AgNOR staining in thyroid cytology. Anal Quant Cytol Histol 20: 187-191."},{"issue":"3","key":"15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1159\/000332685","volume":"41","year":"1997","ISSN":"https:\/\/id.crossref.org\/issn\/0001-5547","issn-type":"print"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Miller B, Burkey S, Lindberg G, Snyder WH 3rd, Nwariaku FE (2004) Prevalence of malignancy within cytologically indeterminate thyroid nodules. Am J Surg 188: 459-462.","DOI":"10.1016\/j.amjsurg.2004.07.006"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Dosen D, Turic M, Smalcelj J, Janusic R, Grgic MP, Separovic V (2003) The value of frozen section in intraoperative surgical management of thyroid follicular carcinoma. Head Neck 25: 521-528.","DOI":"10.1002\/hed.10251"},{"key":"18","unstructured":"18. Paphavasit A, Thompson GB, Hay ID, Grant CS, van Heerden JA, Ilstrup DM, Schleck C, Goellner JR (1997) Follicular and H&uuml;rthle cell thyroid neoplasms. Is frozen-section evaluation worthwhile? Arch Surg 132: 674-679."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ferreira JA, Myers JD, Bostwick DG (1995) Accuracy of frozen section diagnosis in surgical pathology. Review of a 1-year experience with 24,880 cases at Mayo Clinic, Rochester. Mayo Clinic Proc 70: 1137-1141.","DOI":"10.4065\/70.12.1137"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. McHenry CR, Raeburn C, Strickland T, Marty JJ (1996) The utility of routine frozen section examination for intraoperative diagnosis of thyroid cancer. Am J Surg 172: 658-661.","DOI":"10.1016\/S0002-9610(96)00302-9"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kingstorn GW, Bugis SP, Davis N (1992) Role of frozen section and clinical parameters in distinguishing benign from malignant follicular neoplasms of the thyroid. Am J Surg 164: 603-605.","DOI":"10.1016\/S0002-9610(05)80716-0"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Hirokawa M, Carney JA, Goellner JR, DeLellis RA, Heffess CS, Katoh R, Tsujimoto M, Kakudo K (2002) Observer variation of encapsulated follicular lesions of the thyroid gland. Am J Surg Pathol 26: 1509-1514.","DOI":"10.1097\/00000478-200211000-00014"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Udelsman R, Westra WH, Donovan PI, Sohn TA, Carmeron JL (2001) Randomized prospective evaluation of frozen-section analysis for follicular neoplasms of the thyroid. Ann Surg 233: 716-722.","DOI":"10.1097\/00000658-200105000-00016"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1007\/s005950200167"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Monzani F, Caraccio N, Iacconi P, Faviana P, Dardano A, Basolo F, Miccoli P (2003) Prevalence of cancer in follicular thyroid nodules: is there still a role for intraoperative frozen section analysis? Thyroid 13: 389-394.","DOI":"10.1089\/105072503321669884"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Franc B, de la Salmoniere P, Lange F, Hoany C, Louvel A, de Roquancourt A, Vilde F, Hejblum G, Chevret S, Chastang C (2003) Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma. Hum Pathol 34: 1092-1100.","DOI":"10.1016\/S0046-8177(03)00403-9"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Cerutti JM, Delcelo R, Amadei MJ, Nakabashi C, Maciel RM, Peterson B, Shoemaker J, Riggins GJ (2004) A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. J Clin Invest 13: 1234-1242.","DOI":"10.1172\/JCI19617"},{"key":"28","unstructured":"28. Aldred MA, Ginn-Pease ME, Morrison CD, Popkie AP, Gimm O, Hoang-Vu C, Krause U, Dralle H, Jhiang SM, Plass C, Eng C (2003) Caveolin-1 and caveolin-2, together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis. Cancer Res 63: 2864-2871."},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601702"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Volante M, Bozzalla-Cassione F, Orlandi F, Papotti M (2004) Diagnostic role of galectin-3 in follicular thyroid tumors. Virchows Arch 444: 309-312.","DOI":"10.1007\/s00428-004-0993-5"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Maruta J, Hishimoto H, Yamashita H, Yamashita H, Noguchi S (2004) Diagnostic applicability of dipeptidyl aminopeptidase IV activity in cytological samples for differentiating follicular thyroid carcinoma from follicular adenoma. Arch Surg 139: 83-88.","DOI":"10.1001\/archsurg.139.1.83"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021690"},{"key":"33","unstructured":"33. Rickert D, Mittermayer C, Lindenfelser R, Biesterfeld S (2000) MIB-1 immunohistometry of follicular adenoma and follicular carcinoma of the thyroid gland. Anal Quant Cytol Histol 22: 229-234."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Maximo V, Preto A, Crespo A, Rocha AS, Machado JC, Soares P, Sobrinho-Simoes M (2004) Core I gene is overexpressed in H&uuml;rthle and non-h&uuml;rthle cell microfollicular adenomas and follicular carcinomas of the thyroid. BMC Cancer 4: 12.","DOI":"10.1186\/1471-2407-4-12"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.50.173"},{"key":"36","unstructured":"36. Nasir A, Catalano E, Calafati S, Cantor A, Kaiser HE, Coppola D (2004) Role of p53, CD44V6 and CD57 in differentiating between benign and malignant follicular neoplasms of the thyroid. In vivo 18: 189-195."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Kammori M, Nakamura K, Hashimoto M, Ogawa T, Kaminishi M, Takubo K (2003) Clinical application of human telomerase reverse transcriptase gene expression in thyroid follicular tumors by fine-needle aspirations using in situ hybridization. Int J Oncol 22: 985-991.","DOI":"10.3892\/ijo.22.5.985"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. McIver B, Grebe SK, Eberhardt NL (2004) The PAX8\/PPAR gamma fusion oncogene as a potential therapeutic target in follicular thyroid carcinoma. Curr Drug Targets Immune Endocr Metabol Disord 3: 221-234.","DOI":"10.2174\/1568008043339802"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021020"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Marques AR, Espadinha C, Frias MJ, Rogue L, Catarino AL, Sobrinho LG, Leite V (2004) Underexpression of peroxisome proliferator-activated receptor (PPAR) gamma in PAX\/PPARgamma-negative thyroid tumours. Br J Cancer 91: 732-738.","DOI":"10.1038\/sj.bjc.6601989"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.51.361"},{"key":"42","unstructured":"42. Barden CB, Shister KW, Zhu B, Guiter G, Greenblatt DY, Zeiger MA, Fahey TJ 3rd (2003) Classification of follicular thyroid tumors by molecular signature: results of gene profiling. Clin Cancer Res 9: 1792-1800."},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Lin JD, Liou MJ, Chao TC, Weng HF, Ho YS (1999) Prognostic variable of papillary and follicular thyroid carcinomas with lymph node metastases and no distant metastases. Endocr-Relat Cancer 6: 109-115.","DOI":"10.1677\/erc.0.0060109"},{"key":"44","doi-asserted-by":"publisher","DOI":"10.1016\/S1072-7515(03)00332-6"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Zettinig G, Fueger BJ, Passler C, Kaserer K, Pirich C, Dudczak R, Niederle B (2002) Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma &mdash; surgery or conventional therapy? Clin Endocrinol 56: 377-382.","DOI":"10.1046\/j.1365-2265.2002.01482.x"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Min JJ, Chung JIK, Lee YJ, Jeong JM, Lee DS, Jang JJ, Lee MC, Cho BY (2001) Relationship between expression of the sodium\/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma. Eur J Nucl Med 28: 639-645.","DOI":"10.1007\/s002590100509"},{"key":"47","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-0785"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Trieb K, Sztankay A, Amberger A, Lechner H, Grubeck-Loebenstein B (1994) Hyperthermia inhibits proliferation and stimulates the expression of differentiation markers in cultured thyroid carcinoma cells. Cancer Lett 87: 65-71.","DOI":"10.1016\/0304-3835(94)90410-3"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Schroder-van der Elst JP, van der Heide D, Romijn JA, Smit JW (2004) Differential effects of natural flavonoids on growth and iodide content in a human Na+\/I-symporter-transfected follicular thyroid carcinoma cell line. Eur J Endocrinol 150: 557-564.","DOI":"10.1530\/eje.0.1500557"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Schmutzler C, Hoang-Vu C, Ruger B, Kohrle J (2004) Human thyroid carcinoma cell lines show different retinoic acid receptor repertoires and retinoid responses. Eur J Endocrinol 150: 547-556.","DOI":"10.1530\/eje.0.1500547"},{"key":"51","unstructured":"51. Wang MY, Lin MT, Liaw KY (2002) Operative strategy in follicular thyroid cancer. J Formos Med Assoc 101: 820-825."},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Chow SM, Law SC, Mendenhall WM, Au SK, Yau S, Yuen KT, Law CC, Lau WH (2002) Follicular thyroid carcinoma: prognostic factors and the role of radioiodine. Cancer 95: 488-498.","DOI":"10.1002\/cncr.10683"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Randolph GW, Daniels GH (2002) Radioactive iodine lobe ablation as an alternative to completion thyroidectomy for follicular carcinoma of the thyroid. Thyroid 12: 989-996.","DOI":"10.1089\/105072502320908321"},{"issue":"843","key":"54","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1259\/bjr.71.843.9616241","volume":"71","year":"1998","ISSN":"https:\/\/id.crossref.org\/issn\/0007-1285","issn-type":"print"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Nishida T, Katayama S, Tsujimoto M, Nakamura J, Matsuda H (1999) Clinicopathological significance of poorly differentiated thyroid carcinoma. Am J Surg Pathol 23: 205-211.","DOI":"10.1097\/00000478-199902000-00010"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Vanhaverbeke G (2004) Follicular carcinoma of the thyroid with poorly differentiated component presenting with an ileal osteoblastic metastasis. Thyroid 14: 858-861.","DOI":"10.1089\/thy.2004.14.858"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Ho YS, Tseng SC, Chin TY, Hsieh LL, Lin JD (1996) p<sup>53<\/sup> mutation in thyroid carcinoma. Cancer Letter 103: 57-63.","DOI":"10.1016\/0304-3835(96)04196-1"},{"key":"58","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1827.2003.01494.x"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Asakawa H, Kobayashi T (2002) Multistep carcinogenesis in anaplastic thyroid carcinoma: a case report. Pathology 34: 94-97.","DOI":"10.1080\/00313020120105732"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Mai KT, Khanna P, Yazdi HM, Perkins DG, Veinot JP, Thomas J, Lamba M, Nair BD (2002) Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, H&uuml;rthle cell and papillary thyroid carcinoma. Pathology 34: 239-244.","DOI":"10.1080\/00313020220131291"},{"key":"61","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M202771200"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Xu G, Pan J, Martin C, Yeung SC (2001) Angiogenesis inhibition in the in vivo antineoplastic effect of manumycin and paclitaxel against anaplastic thyroid carcinoma. J Clin Endocrinol Metab 86: 1769-1777.","DOI":"10.1210\/jc.86.4.1769"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Park JW, Zarnegar R, Kanauchi H, Wong MG, Hyun WC, Ginzinger DG, Lobo M, Cotter P, Duh QY, Clark OH (2005) Troglitazone, the peroxisome proliferator-activated receptor-gamma agonist, induces antiproliferation and redifferentiation in human thyroid cancer cell lines. Thyroid 15: 222-231.","DOI":"10.1089\/thy.2005.15.222"},{"key":"64","unstructured":"64. Hermanek P, Scheibe O, Spiessl B (1987) UICC: TNM classification of malignant tumors. In: ROFO Fortschr Geb Rongenstr Nuklearmed, 4th ed. Springer-Verlag, Berlin, 732."},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Byar DP, Green SB, Dor P, Williams ED, Colon J, van Gilse HA, Mayer M, Sylvester RJ, van Glabbeke M (1979) A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer 15: 1033-1041.","DOI":"10.1016\/0014-2964(79)90291-3"},{"key":"66","unstructured":"66. Hay ID, Grant CS, Taylor WF, McConahey WM (1987) Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102: 1088-1095."},{"key":"67","unstructured":"67. Cady B, Rossi R (1988) An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104: 947-953."},{"key":"68","unstructured":"68. Hay ID, Bergstralh EJ, Geollner JR, Ebersold JR, Grand CS (1993) Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 thorough 1989. Surgery 114: 1050-1058."},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. D'Avanzo A, Ituarte P, Treseler P, Kebebew E, Wu J, Wong M, Duh QY, Siperstein AE, Clark OH (2004) Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome. Thyroid 14: 453-458.","DOI":"10.1089\/105072504323150778"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. D'Avanzo A, Treseler P, Ituarte PH, Wong M, Streja L, Greenspan FS, Siperstein AE, Duh QY, Clark OH (2004) Follicular thyroid carcinoma: histology and prognosis. Cancer 100: 1123-1129.","DOI":"10.1002\/cncr.20081"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Tzen CY, Huang YW, Fu YS (2003) Is atypical follicular adenoma of the thyroid a preinvasive malignancy? Hum Pathol 34: 666-669.","DOI":"10.1016\/S0046-8177(03)00241-7"},{"key":"72","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1827.2002.01310.x"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/53\/4\/53_4_441\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:56:54Z","timestamp":1618297014000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/53\/4\/53_4_441\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.kr-77","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006]]}}}